West Pharmaceutical Services, Inc. (NYSE:WST) Q3 2023 Earnings Conference Call October 26, 2023 9:00 AM ET
Company Participants
Quintin Lai - Vice President of Investor Relations
Eric Green - President & Chief Executive Officer
Conference Call Participants
Paul Knight - KeyBanc Capital Markets
Larry Solow - CJS Securities
Jacob Johnson - Stephens
John Sourbeer - UBS
Matt Larew - William Blair
David Windley - Jefferies
Justin Bowers - Deutsche Bank
Derik De Bruin - Bank of America
Operator
Good day, and thank you for standing by. Welcome to the Third Quarter 2023 West Pharmaceutical Services Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speakes' presentation, there will be a question-and-answer session. [Operator Instructions] Please be advised that today's conference is being recorded.
I would now like to hand the conference over to your speaker today, Quintin Lai, VP of Investor Relations. Please go ahead.
Quintin Lai
Thank you, Michelle. Good morning, and welcome to West's Third Quarter 2023 Conference Call. We issued our financial results this morning and the release has been posted in the Investors section on the company's website located at westpharma.com. This morning, we will review our financial results, provide an update on our business and present an update on our financial outlook for the full year 2023. There is a slide presentation that accompanies today's call and a copy of that presentation is available on the Investors section of our website.
On Slide 4 is our Safe Harbor Statement. Statements made by management on this call and in the accompanying presentation, contain forward-looking statements within the meaning of U.S. federal securities law. These statements are based on our beliefs and assumptions, current expectations, estimates and forecasts. The company's future results are influenced by many factors beyond the control of the company. Actual results could differ materially from past results as well as those expressed or implied in any forward-looking statement made here. Please refer to today's press release as well as any other disclosures made by the company regarding the risks to which it is subject including our 10-K, 10-Q and 8-K reports.
During today's call, management will make reference to non-GAAP financial measures including organic sales growth, adjusted operating profit, adjusted operating profit margin and adjusted diluted EPS. Reconciliations and limitations of the non-GAAP financial measures to the most comparable financial results prepared in conformity to GAAP are provided in this morning's earnings release.